Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season

Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma Ltd., announced the launch of Time To GoTM today, a multi-channel educational camp

Sumitovant's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile

UTSW-led study shows promise for drug to treat upper urinary tract cancers : Newsroom - UT Southwestern, Dallas, Texas

Urovant Sciences® Announces Partnership with Thinx Inc. to Help Americans with Overactive Bladder This Travel Season

Myovant Sciences to Host Fourth Fiscal Quarter and Fiscal Year 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on May 10, 2022

Digital health news, funding round up in the prior week; November 21, 2022

AI helps Stanford researchers show link between first opioid Rx and dependency

Translating Policy into Practice: Sexual Violence Policies and the University

Urinary Tract Stones

Welcome to Urovant Sciences Medical Affairs

More living organ donors needed to save lives, says Quebec advocacy group

Contact Us Battle River Treaty 6 Health Centre

UriVArx® - Clinically Proven Bladder Control - Promote and Support Healthy Bladder Function, Help Reduce Frequency & Maintain Control – 60 capsules : : Health & Personal Care

Overactive Bladder Urology - Top Urologist NYC

Vibrant America Total Tox Burden -Urine Sample – Dr Jaban Moore - Store